Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate (Q77690474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

main subject

Paget's disease of bone

1 reference

P Filipponi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S Cristallini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Policani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Casciari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Gregorio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

543-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

The acute-phase response after bisphosphonate administration

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Aminohexane diphosphonate in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

High-dose pamidronate in the management of resistant Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Paget's disease of bone: reduction of disease activity with oral risedronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Comparison of three intravenous regimens of clodronate in Paget disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Alendronate in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Tiludronate therapy for Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Therapeutic strategy in Paget's disease of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

The effects of intravenous alendronate in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900133-1

7 January 2021

10.1016/S8756-3282(98)00133-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855463%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference